Carvedilol
Product Images NDC 63629-3669

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 63629-3669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (36691)

Label (36691)
This appears to be a label of prescription medication with information on the dosage and storage requirements. The medication is Carvedilol 6.25 mg tablet, manufactured by Aulife Pharma LLC. It comes in a bottle with 120 tablets and must be stored in a container that is light resistant. The label includes the NDC code and an expiration date.*
FDA Label Image

Figure 1. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig1)

Figure 1. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig1)
This appears to be a chart or graph displaying mortality rates for a treatment group versus a placebo group. The x-axis shows a range from 0.03 to 1.0, likely indicating a percentage scale. The y-axis shows mortality rates from 0% to 30%, possibly related to a specific condition or study. The treatment group is labeled as Carvedilol and the placebo group is simply labeled as Placebo. No further information is available.*
FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig2)

Figure 2. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig2)
This text appears to be a medical report or study that classifies patients based on their medical conditions such as age, prior diagnosis of heart failure or hypertension, diabetes, heart rate, presence of angina or myocardial infarction, and treatments received such as thrombolytic therapy or percutaneous transluminal coronary angioplasty (PTCA). It also includes the results of hazard ratio analysis for these patients. Further interpretation would require more context and domain knowledge.*
FDA Label Image

Carvedilol Structure (Carvedilol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.